Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

S. R. Formula 200 mg Liquid is a Health Canada–registered human drug (DIN 02243761) held by Morinda Canada, containing Hypericum Perforatum. Health Canada lists its status as Cancelled Post Market (status date 12 Jul 2006). Nexara Health has matched 45 registrations of Hypericum Perforatum across 9 other regulated markets.

Health Canada registration

DIN02243761
Brand nameS. R. Formula
Active ingredientHypericum Perforatum
Strength200 mg
Dosage formLiquid
RouteOral
CompanyMorinda Canada
StatusCancelled Post Market — 12 Jul 2006
ClassHuman
ATC
AHFS92:01.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Hypericum Perforatum registered in other markets

45 registrations of the same molecule in 9 national registries outside Canada (first 23 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
BrazilHyperativBionatus Laboratório Botânico Ltda300 MG COM REV CT BL AL PLAS PVC TRANS X 45FitoterápicoCMED
Czech RepublicHypericum Perforatum—2CH-30CHGraRSUKL DLP
FinlandHypericum PerforatumDCG Nordic ABD6,D12,D30,D200,M,CM,LM IV,C6-C10000pilleriRekisteröinti myönnettyFimea Perusrekisteri
IrelandHypericumA. Nelson & Company LimitedPillulesNot marketedHPRA
MalaysiaGnc Herbal Plus Standardized-St John`S Wort (300mg)Gnc Livewell Malaysia Sdn. Bhd.Natural ProductPRODUCT APPROVEDNPRA
NetherlandsHypericum perforatumHeel Belgium n.v.Uitsluitend apotheek of drogistEU national register
NetherlandsHypericum perforatumHeel Belgium n.v.Uitsluitend apotheek of drogistEU national register
NetherlandsHypericum perforatumHeel Belgium n.v.Uitsluitend apotheek of drogistEU national register
NetherlandsHypericum perforatumHeel Belgium n.v.Uitsluitend apotheek of drogistEU national register
United Arab EmiratesHypericum Perforatum - BoironBOIRON, France, Messimy2 DH - 200 CHPillulesActiveEDE
United Arab EmiratesHypericum perforatum - Dr. ReckewegPHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO. GMBH, Germany, BENSHEIMMT - 200CDropsActiveEDE
United KingdomHypericum perforatum 30c homeopathic pillules—0001NHS dm+d VMP
United KingdomHypericum perforatum 30c homeopathic tablets—0001NHS dm+d VMP
United KingdomHypericum perforatum 6c homeopathic pillules—0001NHS dm+d VMP
United KingdomHypericum perforatum 6c homeopathic tablets—0001NHS dm+d VMP
United StatesBestmade Natural Products HypericumBestmade Natural ProductsTablet, SolublelistedFDA NDC
United StatesFrankincense and Myrrh Arthritis Pain TherapyWise Consumer Products Co.LotionlistedFDA NDC
United StatesHypericumEnergique, IncLiquidlistedFDA NDC
United StatesHypericum PerfHyland's Inc.TabletlistedFDA NDC
United StatesHypericum perforatumBoironPelletlistedFDA NDC
United StatesHypericum perforatumBoironPelletlistedFDA NDC
United StatesHypericum perforatumBoironPelletlistedFDA NDC
United StatesHypericum perforatumBoironPelletlistedFDA NDC

See every manufacturer of Hypericum Perforatum worldwide →

Regulator price references for Hypericum Perforatum

Published list or reimbursement prices for Hypericum Perforatum presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
BrazilHyperativ300mg300 MG COM REV CT BL AL PLAS PVC TRANS X 4582.37 BRLpreco fabrica (ex-factory ceiling)CMED2026-09-02

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is S. R. Formula (DIN 02243761) marketed in Canada?

No. Health Canada lists DIN 02243761 as Cancelled Post Market as of 12 Jul 2006.

Who holds the Canadian licence for this product?

Morinda Canada is the company of record in the Health Canada Drug Product Database.

Is Hypericum Perforatum registered outside Canada?

Yes — Nexara Health has matched 45 registrations in 9 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02243761, status date 2006-07-12; national medicine registries: CMED, EDE, EU national register, FDA NDC, Fimea Perusrekisteri, HPRA, NHS dm+d VMP, NPRA, SUKL DLP; price sources: CMED. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02243761, status date 2006-07-12; national medicine registries: CMED, EDE, EU national register, FDA NDC, Fimea Perusrekisteri, HPRA, NHS dm+d VMP, NPRA, SUKL DLP; price sources: CMED.

Health Canada Drug Product Database (DPD), DIN 02243761, status date 2006-07-12; national medicine registries: CMED, EDE, EU national register, FDA NDC, Fimea Perusrekisteri, HPRA, NHS dm+d VMP, NPRA, SUKL DLP; price sources: CMED. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.